Dexcom enters VC space

SAN DIEGO – Dexcom has launched Dexcom Ventures to identify and invest in opportunities to supplement growth in its core business of continuous glucose monitoring and advance the development of adjacent technologies. 

Dexcom Ventures, led by Dexcom veteran Steve Pacelli, will be focused on investment opportunities in sensing technology, data analytics, remote patient monitoring and population health, broadening the company’s commitment to advancing better outcomes in health care. 

“Driven by core technologies that our teams have developed internally, Dexcom continues to achieve strong growth and expand our future markets,” said Kevin Sayer, chairman, president and CEO. “By establishing Dexcom Ventures, we believe we can advance innovative technologies that enable better health outcomes and complement our growth opportunity. I have full confidence in Steve and his team as they lead this exciting new effort.” 

Pacelli has been executive vice president of strategy and corporate development at Dexcom since 2012. 

The fund will support independent initiatives in glucose testing technologies and in adjacent fields of metabolic monitoring, with a “start-up” mentality, Pacelli says. 

“We strive to be value-add strategic investors by leveraging access to Dexcom’s unique industry experience and technology leadership,” he said. “While we have matured as a company over the years, we still consider ourselves to be a ‘start up’ of sorts. We feel well positioned to invest early and support our portfolio companies as they pioneer markets.”